Todd Alfred Carter, Chief Scientific Officer: Voyager Therapeutics VYGR Sell · Filed 23/03/22

Trade details

Type: Insider sale
Amount: $17,017.68
Shares · price: 2,193 sh · $7.76 a share
Held after: 65,360 sh
Stock: Voyager Therapeutics VYGR
Person: Todd Alfred CarterChief Scientific Officer
Trade date: 23/03/20
Filed: 23/03/22
Days to filing: 2 days

Sold 3.2% of holdings

Share of holding sold: 3.2%

Voyager Therapeutics trades, last 26 weeks

What else happened in Voyager Therapeutics around then

Filed or reported within 30 days of the trade day · 23/02/18~23/04/19

Todd Alfred Carter's recent trades

Todd Alfred CarterChief Scientific Officer
Sell10b5-1 planVoyager Therapeutics
Sell10b5-1 plan
Voyager Therapeutics
VYGR
$15.7K
4,174 sh
$15.7K
Filed 02/26
Traded 02/24
Todd Alfred CarterChief Scientific Officer
Planned saleVoyager Therapeutics
Planned sale
Voyager Therapeutics
VYGR
$15.7K
4,174 sh
$15.7K
Filed 02/24
Traded 02/24
Todd Alfred CarterChief Scientific Officer
Sell10b5-1 planVoyager Therapeutics
Sell10b5-1 plan
Voyager Therapeutics
VYGR
$11.4K
3,301 sh
$11.4K
Filed 02/20
Traded 02/18
Todd Alfred CarterChief Scientific Officer
Planned saleVoyager Therapeutics
Planned sale
Voyager Therapeutics
VYGR
$11.3K
3,301 sh
$11.3K
Filed 02/18
Traded 02/18
Todd Alfred CarterChief Scientific Officer
SellVoyager Therapeutics
Sell
Voyager Therapeutics
VYGR
$13.6K
3,525 sh
$13.6K
Filed 02/11
Traded 02/10